Lukas Bubendorf

Research interests

Publications

• IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

  Journal of Thoracic Oncology · 2020 · https://doi.org/10.1016/j.jtho.2020.01.005

• The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

  Journal of Thoracic Oncology · 2020 · 10.1016/j.jtho.2020.05.019

• A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

  Journal of Thoracic Oncology · 2020 · 10.1016/j.jtho.2020.06.001

• PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

  Journal of Thoracic Oncology · 2019 · 10.1016/j.jtho.2019.12.107

• PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.05.013

• Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

  Journal of Thoracic Oncology · 2018 · 10.1016/j.jtho.2018.12.005

• Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

  Clinical Cancer Research · 2018 · 10.1158/1078-0432.ccr-18-1590

• Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

  Annals of Oncology · 2014 · 10.1093/annonc/mdu145

• 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

  Annals of Oncology · 2014 · 10.1093/annonc/mdu123

• 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

  Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu089

• Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study

  The Lancet Oncology · 2012 · 10.1016/s1470-2045(12)70476-x

• Stat3 Promotes Metastatic Progression of Prostate Cancer

  American Journal Of Pathology · 2008 · 10.2353/ajpath.2008.071054

• Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

  British Journal of Cancer · 2006 · 10.1038/sj.bjc.6602924

• Elevated expression of inhibitor of apoptosis proteins in prostate cancer.

  PubMed · 2003

• Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer

  JNCI Journal of the National Cancer Institute · 2001 · 10.1093/jnci/93.15.1141

• Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

  The Journal of Pathology · 2001 · 10.1002/1096-9896(200107)194:3<349::aid-path887>3.0.co;2-d

• Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studies

  The Journal of Pathology · 2001 · 10.1002/path.893

• Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray Analysis

  JNCI Journal of the National Cancer Institute · 2000 · 10.1093/jnci/92.15.1252

• Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

  PubMed · 2000

• Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients

  Human Pathology · 2000 · https://doi.org/10.1053/hp.2000.6698

• Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

  PubMed · 1999

• High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma

  American Journal Of Pathology · 1999 · 10.1016/s0002-9440(10)65349-7

• Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays

  JNCI Journal of the National Cancer Institute · 1999 · 10.1093/jnci/91.20.1758

• Tissue microarrays for gene amplification surveys in many different tumor types.

  PubMed · 1999

• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  Nature Medicine · 1998 · 10.1038/nm0798-844

Current projects

No projects listed.